Literature DB >> 17959000

Bacterial contamination of hospital bed-control handsets in a surgical setting: a potential marker of contamination of the healthcare environment.

R R W Brady1, P Kalima, N N Damani, R G Wilson, M G Dunlop.   

Abstract

INTRODUCTION: Patients undergoing colorectal surgical resections have a high incidence of surgical site infection (SSI). Many patient-specific risk factors have been recognised in association with SSI in such patients, but environmental contamination is increasingly recognised as a contributor to hospital-acquired infection (HAI). This study set out to describe the bacterial contamination of the patient environment, using hospital bed-control handsets, as they are frequently handled by both staff and patients and represent a marker of environmental contamination. PATIENTS AND METHODS: On two unannounced sampling events, 1 week apart, 140 bacteriological assessments were made of 70 hospital bed control handsets within a specialist colorectal surgical unit.
RESULTS: Of the handsets examined, 67 (95.7%) demonstrated at least one bacterial species (52.9% grew 1, 30% grew 2 and 12.9% grew 3 or more bacterial species). Of these, 29 (41.4%) bed-control handsets grew bacteria known to cause nosocomial infection, including 22 (31.4%) handsets which grew Enterococcus spp., 9 (12.9%) which grew MRSA, 2 (2.9%) which grew MSSA, 2 (2.9%) which grew coliforms, and 1 (1.4%) handset which grew anaerobes. At 1-week follow-up, 31 bed-control handsets showed evidence of contamination by the same bacterial species.
CONCLUSIONS: This study revealed high levels of bacteria known to cause HAI, contaminating hospital bed-control handsets in a surgical setting. Further study is now required to confirm whether hospital environmental contamination is causally involved in SSI.

Entities:  

Mesh:

Year:  2007        PMID: 17959000      PMCID: PMC2121295          DOI: 10.1308/003588407X209347

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  25 in total

Review 1.  Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials.

Authors:  F Song; A M Glenny
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

2.  Impact of postoperative infections on survival in colon cancer patients.

Authors:  Angelo Nespoli; Luca Gianotti; Giorgio Bovo; Fernando Brivio; Luca Nespoli; Mauro Totis
Journal:  Surg Infect (Larchmt)       Date:  2006       Impact factor: 2.150

3.  Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.

Authors:  J M Boyce; G Potter-Bynoe; C Chenevert; T King
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

4.  Blood transfusions and postoperative wound infection.

Authors:  C D Ford; G VanMoorleghem; R L Menlove
Journal:  Surgery       Date:  1993-06       Impact factor: 3.982

5.  Relationship of blood transfusion, post-operative infections and immunoreactivity in patients undergoing surgery for gastrointestinal cancer.

Authors:  L Quintiliani; A Pescini; M Di Girolamo; P Iudicone; F Martini; M Guglielmetti; A Buzzonetti; S Fascioli
Journal:  Haematologica       Date:  1997 May-Jun       Impact factor: 9.941

6.  Postoperative infections in colorectal cancer patients.

Authors:  Matija Horzic; Mario Kopljar
Journal:  Hepatogastroenterology       Date:  2005 Jan-Feb

7.  Compliance with handwashing in a teaching hospital. Infection Control Program.

Authors:  D Pittet; P Mourouga; T V Perneger
Journal:  Ann Intern Med       Date:  1999-01-19       Impact factor: 25.391

8.  Wound infection after elective colorectal resection.

Authors:  Robert L Smith; Jamie K Bohl; Shannon T McElearney; Charles M Friel; Margaret M Barclay; Robert G Sawyer; Eugene F Foley
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

9.  Intra-abdominal sepsis and survival after surgery for colorectal cancer.

Authors:  P P Varty; I P Linehan; P B Boulos
Journal:  Br J Surg       Date:  1994-06       Impact factor: 6.939

10.  Perioperative blood transfusion associated with infectious complications after colorectal cancer operations.

Authors:  P I Tartter; S Quintero; D M Barron
Journal:  Am J Surg       Date:  1986-11       Impact factor: 2.565

View more
  7 in total

1.  Infection-free surgery: how to improve hand-hygiene compliance and eradicate methicillin-resistant Staphylococcus aureus from surgical wards.

Authors:  C R Davis
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

2.  DEVELOPMENT OF VOICE-CONTROLLED SMART SURGICAL BED.

Authors:  Jeong Hun Kim; Richard Um; Nicholas Theodore; Rajiv Iyer; Amir Manbachi
Journal:  Des Med Devices Conf (2020)       Date:  2020-07-27

3.  Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Megan R Kiedrowski; Jeffrey S Kavanaugh; Cheryl L Malone; Joe M Mootz; Jovanka M Voyich; Mark S Smeltzer; Kenneth W Bayles; Alexander R Horswill
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

4.  Culture-independence for surveillance and epidemiology.

Authors:  Benjamin C Kirkup
Journal:  Pathogens       Date:  2013-09-24

5.  Contamination of the Surfaces of a Health Care Environment by Multidrug-Resistant (MDR) Bacteria.

Authors:  Laila Chaoui; RajaaAit Mhand; Fouad Mellouki; Naima Rhallabi
Journal:  Int J Microbiol       Date:  2019-11-29

Review 6.  Methicillin Resistant Staphylococcus aureus and public fomites: a review.

Authors:  Ziad W Jaradat; Qutaiba O Ababneh; Sherin T Sha'aban; Ayesha A Alkofahi; Duaa Assaleh; Anan Al Shara
Journal:  Pathog Glob Health       Date:  2020-10-28       Impact factor: 2.894

7.  Bacterial Pathogens and Their Antimicrobial Resistance Patterns of Inanimate Surfaces and Equipment in Ethiopia: A Systematic Review and Meta-analysis.

Authors:  Teklehaimanot Kiros; Shewaneh Damtie; Tahir Eyayu; Tegenaw Tiruneh; Wasihun Hailemichael; Lemma Workineh
Journal:  Biomed Res Int       Date:  2021-05-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.